Medtronic (NYSE:MDT) announced Tuesday that the U.S. Food and Drug Administration has approved its heart devices for treating people who suffer from mild symptoms of heart failure through an expanded indication.Previously, cardiac resynchronization therapy with implantable cardioverter defibrillator devices was approved only for those who showed moderate to severe symptoms. Under the current expanded approval, [...]
[Read more of this report]Johnson & Johnson (NYSE:JNJ) is the third most reputable U.S. company, according to an annual online survey of more than 10,000 people conducted by Reputation Institute. The survey asked consumers about their knee-jerk reactions to 150 of the biggest companies in the U.S., did some number crunching, and produced a list that also included CVS, [...]
[Read more of this report]Medtronic (NYSE:MDT) announced Friday that it will pay $85 million to settle a class action securities fraud lawsuit related to its controversial bone growth product Infuse, but denied any wrongdoing.The Minneapolis Firefighters’ Relief Association brought the lawsuit against the device maker and alleged that the company and some of its current and former officers misrepresented [...]
[Read more of this report]New data suggests that the risk of stroke related to the emerging therapy of transcatheter aortic value replacement is not as high as previously thought.At the American College of Cardiology meeting in Chicago earlier this week, both Edwards Lifesciences (NYSE:EW) and Medtronic (NYSE:MDT) reported a lower risk for stroke for this therapy. It is considered [...]
[Read more of this report]Roughly three years after acquiring Ventor Technologies for $325 million, Medtronic (NYSE:MDT)is closing the Israeli operation and laying off 55 employees, according to an Israeli publication.Ventor Technologies brought transcatheter aortic valve technologies to Medtronic.A Medtronic spokesman confirmed Thursday that Ventor’s operations will cease in Israel, noting that the move is part of the company’s plan [...]
[Read more of this report]Medtronic (NYSE:MDT) announced Thursday that the company’s Deep Brain Stimulation therapy has been approved to treat refractory epilepsy patients in Canada.Refractory epilepsy patients suffer from recurring seizures that cannot be controlled by medication.The Canadian approval was based on the results of a randomized, controlled, double-blind study that observed 110 patients who were implanted with the [...]
[Read more of this report]With a key FDA approval in hand for its cardiac ablation technology, device maker AtriCure (NASDAQ:ATRC) has its sights set on grabbing market share from industry giant Medtronic (NYSE:MDT).In December, AtriCure’s Synergy ablation system became the first medical device to receive U.S. Food and Drug Administration approval for the surgical treatment of atrial fibrillation (AF), [...]
[Read more of this report]It seems like implanted cardioverter defibrillators have some kind of evil eye upon them.Minnesota device maker Medtronic warned physicians this week that its EnTrust and Escudo ICDs run the risk of early battery depletion. Last year, Medtronic’s in-state rival St. Jude Medical was hit with a Class I recall of its Riata and the Riata [...]
[Read more of this report]Developing an artificial pancreas is the Holy Grail for diabetes patients.This week, Medtronic announced that it was inching closer to this becoming a reality by proving the efficacy of its MiniMed Paradigm System featuring Low Glucose Suspend (LGS) automation in a landmark clinical study. This pump with a sensor has the ability to automatically suspend [...]
[Read more of this report]Last year, Jerome Radcliffe caught Medtronic off guard when he hacked into his own insulin pump. No one had attempted such a thing before, at least not successfully.This year, it has happened again. Bloomberg News reports that another person has proved he can hack into an insulin pump and command it to deliver a lethal [...]
[Read more of this report]